Delhi High Court Safeguards PHENSEDYL Mark from Infringement and Passing Off

Aadrikaa Legal Services (ALS)- Law I Litigation I Arbitration

Date: 05.09.2026

Delhi High Court Safeguards PHENSEDYL Mark from Infringement and Passing Off

A recent judgment by the Delhi High Court has set a significant precedent in the field of pharmaceutical trademark protection. The case, Opella Healthcare Group vs. Pureca Laboratories Pvt Ltd, revolved around the alleged infringement and passing off of the well-known trademark “PHENSEDYL” by the defendant’s use of the mark “PHENSERYL”. This article provides a detailed overview of the case, the court’s findings, and its broader implications for intellectual property rights in the pharmaceutical sector.

Background of the Case

• Plaintiff: Opella Healthcare Group, part of the global Sanofi Group, a major player in pharmaceuticals.
• Defendant: Pureca Laboratories Pvt Ltd.
• Dispute: The plaintiff alleged that the defendant’s use of the mark “PHENSERYL” and similar packaging was deceptively similar to their registered trademark “PHENSEDYL”, leading to trademark infringement and passing off.

Key Facts

1. History of the PHENSEDYL Mark:
   • Adopted in 1954 for pharmaceutical products treating symptoms like running nose, sneezing, and throat irritation.
   • Registered in India since 21 July 1954 in Class 05 (pharmaceutical preparations for human and veterinary use).
   • Widely marketed in India since 1995, with distinctive blue and pink packaging.
2. Defendant’s Actions:
   • Registered the mark “PHENSERYL” in Class 05, claiming use since December 2016.
   • Adopted similar trade dress and packaging, leading to confusion among consumers.
3. Legal Proceedings:
   • Plaintiff filed for a permanent injunction and rectification of the defendant’s trademark and copyright registrations.
   • The court had previously cancelled the defendant’s registrations, finding them deceptively similar to the plaintiff’s mark.

Court’s Analysis and Findings

• Ex Parte Proceedings: The defendant failed to appear in court, and the matter proceeded ex parte.
• Prior Use and Goodwill: The court recognized Opella Healthcare Group as the prior adopter and continuous user of the “PHENSEDYL” mark, with substantial goodwill and reputation in India.
• Deceptive Similarity:
  • The marks “PHENSEDYL” and “PHENSERYL” were found to be visually and phonetically similar.
  • The packaging and trade dress used by the defendant closely resembled that of the plaintiff, increasing the likelihood of consumer confusion.
• Public Interest in Pharmaceuticals:
  • The court emphasized that confusion in pharmaceutical products can be life-threatening, not just inconvenient, citing Supreme Court precedent.
  • A higher threshold for proving confusing similarity applies in the pharmaceutical sector.
• Summary Judgment:
  • The court granted summary judgment in favor of the plaintiff, noting that the defendant had no real prospect of defending the claims.
  • The suit was decreed in favor of Opella Healthcare Group, granting a permanent injunction against the defendant.

Implications of the Judgment

1. Strengthening Trademark Protection:
   • The judgment reinforces the importance of protecting established pharmaceutical trademarks against deceptively similar marks.
2. Consumer Safety:
   • By preventing confusion between medicinal products, the court prioritized public health and safety.
3. Judicial Efficiency:
   • The use of summary judgment procedures in commercial disputes ensures timely resolution, especially when the defendant lacks a credible defense.

Conclusion

The Delhi High Court’s decision in Opella Healthcare Group vs. Pureca Laboratories Pvt Ltd is a landmark in pharmaceutical trademark law. It underscores the judiciary’s commitment to protecting intellectual property, ensuring consumer safety, and promoting fair competition in the pharmaceutical industry.

Connected Matter

Delhi High Court Invalidates Trademark Assignment, Affirms Corporate Ownership of ‘Su-Kam’ Brand

Aadrikaa Legal Services is a trusted legal and regulatory support partner providing end-to-end legal solutions to law firms, corporate organizations, and businesses across India. We specialize in paralegal services, litigation support, tax and regulatory matters, delivering reliable, efficient, and result-oriented legal assistance.

Our services include comprehensive paralegal support, drafting and documentation, legal research, case management, litigation handling, and representation support across various judicial and quasi-judicial forums. We also assist in direct and indirect tax matters, customs, GST, corporate regulatory compliance, and legal advisory.

Source: Delhi High Court

Disclaimer

Handy Download:

Write to us at office@aadrikaalaw.com

Tel: +91-11-4999 2707

www.aadrikaalaw.com

Ravi Shekhar Jha – Advocate, Bar Council of Delhi